Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-10141.0%
operating margin TTM
-4242.24%
revenue TTM
12.20 Thousand
revenue per share TTM
0.02$
valuation ratios | |
|---|---|
| pe ratio | -0.91 |
| peg ratio | 0.01 |
| price to book ratio | 1.28 |
| price to sales ratio | 56.05 |
| enterprise value multiple | -0.78 |
| price fair value | 1.28 |
profitability ratios | |
|---|---|
| gross profit margin | -253.38% |
| operating profit margin | -4242.24% |
| pretax profit margin | -10313.33% |
| net profit margin | -10141.0% |
| return on assets | -105.68% |
| return on equity | -102.59% |
| return on capital employed | -54.48% |
liquidity ratios | |
|---|---|
| current ratio | 1.40 |
| quick ratio | 1.40 |
| cash ratio | 1.37 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 110.63 |
| days of payables outstanding | 939.67 |
| cash conversion cycle | -829.04 |
| receivables turnover | 3.30 |
| payables turnover | 0.39 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | -1,161.14 |
| cash flow to debt ratio | -62.20 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.82 |
| cash per share | 1.39 |
| operating cash flow per share | -1.82 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -62.20 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Addex Therapeutics Ltd (NASDAQ:ADXN) reported earnings?
Addex Therapeutics Ltd (ADXN) published its most recent earnings results on 30-09-2025.
What is Addex Therapeutics Ltd's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Addex Therapeutics Ltd (NASDAQ:ADXN)'s trailing twelve months ROE is -102.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Addex Therapeutics Ltd (ADXN) currently has a ROA of -105.68%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADXN's net profit margin stand at?
ADXN reported a profit margin of -10141.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADXN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.40 in the most recent quarter. The quick ratio stood at 1.40, with a Debt/Eq ratio of 0.01.